CHMP5 and COVID-19: As reported by several studies, the Omicron variant and its subvariants demonstrate a strong ability to escape the neutralizing antibody elicited by the initial COVID-19 vaccination, previous infection, and monoclonal antibodies due to multiple mutations that are present in their spike proteins [25,26,27].